RE: Great update30 Mar 2026 08:50
£250k revenue is significant, equivalent to 12.7% of FY 2025 revenue (£1.96m). And that's just from one deal, for 1 molecule, with a company that will continue to use FAB's services. And squeezed into FY 2026 which ends tomorrow.
More such announcements and the juicy NVI deal to come, looking good 👍